SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-19-001222
Filing Date
2019-05-01
Accepted
2019-05-01 16:53:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da112274002_05012019.htm SC 13D/A 314010
2 JOINT FILING AGREEMENT ex991to13da112274002_050119.htm EX-99.1 16612
  Complete submission text file 0000921895-19-001222.txt   332137
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Subject) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-52343 | Film No.: 19788322
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1055B POWERS PLACE SUITE 810 ALPHARETTA GA 30009
Business Address 5348 VEGAS DR., UNIT 733 LAS VEGAS NV 89108 404-664-3629
Altiva Management Inc. (Filed by) CIK: 0001772491 (see all company filings)

IRS No.: 821992901 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A